Keyword Connections

metastatic breast cancer

Journals

10

1 International journal of molecular sciences

2 clinical & translational oncology : official publication of the federation of spanish oncology societies and of the national cancer institute of mexico

3 Human molecular genetics

4 Journal of the College of Physicians and Surgeons--Pakistan : JCPSP

5 Cancer investigation

6 psycho-oncology

7 journal of palliative medicine

8 the breast journal

9 preventing chronic disease

10 Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Research Groups

0

No Research Group Connected

Bibliographies

42

1 Outcome and feasibility of palliative chemotherapy in very elderly patients with metastatic breast cancer.

2 Promoting Cancer Screening in Partnership With Health Ministries in 9 African American Churches in South Los Angeles: An Implementation Pilot Study.

3 Greater Mindfulness Associated With Lower Pain, Fatigue, and Psychological Distress in Women with Metastatic Breast Cancer.

4 A Trans-ancestral Meta-Analysis of Genome-Wide Association Studies Reveals Loci Associated with Childhood Obesity.

5 Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.

6 "I'd Want to Know, Because a Year's Not a Long Time to Prepare for a Death": Role of Prognostic Information in Shared Decision Making among Women with Metastatic Breast Cancer.

7 Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer.

8 the fibroblast growth factor receptors in breast cancer: from oncogenesis to better treatments

9 Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancer.

10 Prognostic Markers after Hepatic Function Impairment in Patients with Pancreatic Adenocarcinoma.

11 Concomitant Use of Ado-trastuzumab Emtansine and Imatinib in a Patient of CML and Metastatic Breast Cancer.

12 Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.

13 Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecan.

14 Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast Cancer.

15 Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment

16 Impact of NCI Socioeconomic Index on the Outcomes of Nonmetastatic Breast Cancer Patients: Analysis of SEER Census Tract-Level Socioeconomic Database.

17 The PI3K/AKT/mTOR and CDK4/6 pathways in endocrine resistant HR+/HER2- metastatic breast cancer: Biological mechanisms and new treatments

18 Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.

19 Guideline Discordance and Patient Cost Responsibility in Medicare Beneficiaries With Metastatic Breast Cancer.

20 Reply to “Letter to the Editor” intent of surgery of the primary tumor in metastatic breast cancer remains palliative

21 Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer

22 PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy

23 Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.

24 "The day you lose your hope is the day you start to die": Quality of life measured by young women with metastatic breast cancer.

25 High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.

26 Palbociclib and beyond for the treatment of HR + HER2- metastatic breast cancer: An Asian-Pacific perspective and practical management guide on the use of CDK4/6 inhibitors.

27 Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index

28 Evaluation of the HER2 and Hormone Receptor Status in Metastatic Breast Cancer Using Cell Blocks: A Multi-Institutional Study

29 effect of central nervous system metastases on treatment discontinuation and survival in older women receiving trastuzumab for metastatic breast cancer

30 nanoparticle-mediated therapeutic agent delivery for treating metastatic breast cancer—challenges and opportunities

31 changes in water mobility measured by diffusion mri predict response of metastatic breast cancer to chemotherapy

32 development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype

33 targeted treatment of advanced and metastatic breast cancer with lapatinib

34 safety and efficacy of tien-hsien liquid practical in patients with refractory metastatic breast cancer: a randomized, double-blind, placebo-controlled, parallel-group, phase iia trial

35 targeting metastatic breast cancer with ang1005, a novel peptide-paclitaxel conjugate that crosses the blood-brain-barrier (bbb)

36 time-dependent prognostic impact of circulating tumor cells detection in non-metastatic breast cancer: 70-month analysis of the remagus02 study

37 Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.

38 Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2- Metastatic Breast Cancer: A Podcast.

39 Ethanolic Extract of Hedyotis corymbosa L. Inhibits Migration and MMP-9 Activity on Metastatic Breast Cancer Cells

40 Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer.

41 The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancer.

42 Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.